Global investment firm The Carlyle Group (NASDAQ: CG) and the existing promoters of SeQuent Scientific Limited (BSE-512529; NSE: SEQUENT) announced that CA Harbor Investments, an affiliated entity of CAP V Mauritius Limited and The Carlyle Group (together, “Carlyle”), has agreed to acquire an equity stake of up to 74% in SeQuent Scientific Limited (“SeQuent”), the largest pure-play animal healthcare company in India. Headquartered in Mumbai, SeQuent is the largest Indian pure-play animal healthcare company with global operations. SeQuent provides animal health Active Pharmaceutical Ingredients (“API”), formulations, and analytical services in over 100 countries, with more than 1,700 employees and manufacturing operations in India, Spain, Turkey, Germany and Brazil.
Read the full article: The Carlyle Group Enters into Binding Agreements to Acquire a Majority Stake in SeQuent Scientific Limited //
Source: https://www.carlyle.com/media-room/news-release-archive/carlyle-group-enters-binding-agreements-acquire-majority-stake